Eli Lilly stock slips after Novo Nordisk trims 2025 forecast; Jaypirca meets endpoint in CLL trial against J&J's Imbruvica, ...

Eli Lilly and Company (LLY) on Tuesday said that its cancer drug Jaypirca was more effective than AbbVie’s drug Imbruvica in ...

This peer was Novo Nordisk, which like Eli Lilly sells a popular drug approved specifically for obesity. Eli Lilly's recent popularity is due in no small measure to its plunge into the highly ...

Diabetes and obesity boom will propel Lilly, Novo to front of pharma sales pack by 2030: Evaluate By Kevin Dunleavy Jun 23, 2025 9:52am Evaluate Pharma Eli Lilly GLP-1 Mounjaro ...

ENDOWMENT INC LILLY has made 0 purchases and 51 sales selling 534,452 shares for an estimated $474,544,560. DANIEL SKOVRONSKY (EVP, CSO & Pres. LRL & LLY Imm) has made 0 purchases and 3 sales ...

We recently published a list of the 10 Best Long-Term Dividend Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY ...